D-Wave Quantum: A Non-Binding Korean Pact, a Prize-Winning Japanese Study and a Machine Bound for Italy
Published on 10/29/2026 at 18:31 | Editorial boerse-global.de
Three separate announcements from D-Wave Quantum this week sit at very different points on the road from laboratory curiosity to booked revenue — and investors who treat them as interchangeable are misreading the company's actual position. A non-binding memorandum with LG CNS, a research award won by customer Shionogi, and the arrival of an Advantage2 system in Italy each describe a distinct stage of commercial maturity. The next hard checkpoint comes on November 10, when the company reports third-quarter 2026 results before the market opens.
A memorandum is a statement of intent, not an order
The agreement with LG CNS, signed yesterday, is explicitly non-binding. Under the arrangement, the two parties intend to push adoption of quantum-powered optimization among enterprises in South Korea and in international markets. That is a shared objective, not a signed customer contract, and the distinction matters: the word "non-binding" is the single most important term in the release. Its value for now lies in the stated goal of enterprise deployment, nothing more.
Shionogi's news, published the same day, occupies different ground entirely. The Japanese drugmaker took first place in the quality-of-life category of the NEDO Challenge, a competition that came with a prize of ¥40 million intended to support its research into drug discovery using quantum computers. The winner is a customer, and the money is earmarked for that customer's research. For D-Wave it is evidence of an application in the field — but the prize is not the company's own revenue, and the recipient and the purpose of the funds should be kept clearly apart.
Where annealing meets generative AI
What gives the Shionogi result its weight is the method behind it. According to D-Wave, the work included a peer-reviewed study that embedded its annealing technology inside a generative AI model for molecular design. Quantum hardware was not the isolated centerpiece; it became one component of a model built for a specific research task. That is arguably the more instructive angle for shareholders, because it shifts the question from what a quantum computer can do in principle to what D-Wave's technology contributes inside a working application.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
The peer-reviewed study and the award lend that argument substance. They say nothing, however, about what revenue D-Wave will book as a result. Research success, benefit to the customer and commercial success for the technology vendor are three different things — a separation that is not a slight on the science but the necessary translation of a technical headline into an investment view.
Italy: a contract with a number attached
Roughly two weeks ago, the Advantage2 quantum computer arrived in Italy for installation, shipped under a previously announced agreement with Swiss Quantum Technology SA worth €10 million. Set this beside the Shionogi news and the gap in maturity is plain. The Italian arrangement carries a concrete contract value; the delivery for installation marks a step in execution rather than completed operation. Here too, the precise wording governs how far expectations can reasonably be carried.
Taken together, the two developments represent different legs of the journey: Shionogi offers a research-based proof of application, while the Italy project is a contract-backed move toward putting a system in place. Both belong to D-Wave's commercial evolution. They should not be equated.
A court filing that remains an allegation
Any fair reading also has to account for the securities class action filed against D-Wave Quantum on October 15. The case, Fessler v. D-Wave Quantum Inc. et al., was lodged in the U.S. District Court for the Northern District of California. The complaint alleges misleading statements between February 26 and August 25. The deadline for motions to serve as lead plaintiff is December 15. These are allegations in a complaint, not facts established by a court.
D-Wave Quantum at a turning point? This analysis reveals what investors need to know now.
November 10 is where the story gets audited
D-Wave confirmed on Tuesday that it will publish results for the third quarter of 2026 — the period ended September 30 — on November 10, before trading begins. That date moves the focus from individual collaboration and application announcements to the financial record itself. Quarterly figures and the recent corporate news answer different questions: the results cover a period that has closed, while the LG CNS memorandum points to cooperation that has yet to happen.
For investors, the sensible framework separates three layers: intended collaboration, concrete customer applications and reported business results. Encouraging application news is no substitute for binding contracts or for scrutiny of the numbers. By the same token, a filed complaint does not turn its allegations into proven fact.
Ad
D-Wave Quantum Stock: New Analysis - 29 October
Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
